869 medicines including cancer medicines will be expensive: Know more about the medicines

The National Pharmaceutical Pricing Authority (NPPA) has increased the prices of 869 medicines for many other diseases including cancer. NPPA issued the notification and said that the price of these drugs has increased by 3.44 percent as per the revised revision based on the annual wholesale price index. 

CDSCO's new intelligence cell to check illegal activity in India’s pharma sector

The Central Drugs Standard Control Organisation (CDSCO), India’s central drug regulator, has set up a nine-member intelligence cell to track illegal activity in the country’s pharmaceutical sector. 

This includes gathering information on the medicines and cosmetics imported or exported against the law and investigating complaints related to medicine quality received from overseas regulatory agencies, according to an office order dated March 26. 

The intelligence cell will be in charge of collecting and collating information on activities carried out in contravention to the provisions of the Drugs & Cosmetics Act, 1940, stated the order, which ET has seen. 

Details 483 observations: Dr. Reddy's got 5 observations at CTO III. FDA audit held between 5 march to 9 march

FDA audit was held between 5 march to 9 march at CTO III. Dr. Reddy's got 5 483 observations. Click  here for more details

The U. S. drug regulator is conducting a surprise audit at Alkem Laboratories Ltd.’s largest facility in Daman

The U. S. drug regulator is conducting a surprise audit at Alkem Laboratories Ltd.’s largest facility in Daman, Gujarat, two people aware of the development told BloombergQuint requesting anonymity.

Be careful: Chemist still give branded medicine on prescription of generic medicines

Branded medicines are not available in the state. Most of the doctors are writing branded medicines so far. In spite of this, the chemist has now begun to treat branded medicines to patients. People are being cheated due to lack of information about Salt of the drug.

Great initiative:Gujarat FDCA, US FDA to soon meet for discussing training plan for drug regulators towards audit- preparedness

As part of its renewed focus to upgrade compliance levels in 170 US FDA approved units in Gujarat, US FDA and Gujarat Food and Drug Control Administration (FDCA) would soon meet to chalk out a plan for training drug inspectors for effective oversight and audit preparedness in manufacturing facilities.

Great news: Sun Pharma gets US FDA nod for its specialty psoriasis drug Ilumya

Sun Pharmaceutical Industries, India’s largest drug maker, Wednesday said it got US FDA approval for its much awaited psoriasis drug Ilumya.

Audit report:Cipla Says Eight Observations By U.S. FDA For Goa Unit Are Procedural

Cipla Ltd. received eight observations regarding manufacturing practices at its Goa plant that contributes a quarter of the drugmaker’s sales in the U.S.

Drug companies are in radar

Drugs and appliances scandal in the health department have started to open. It is worth noting that keeping the rules in Rewari, the tender of the drug pichchase was given to the company named Sagan in Hisar, which did not have the eligibility involved in the bid. Surprisingly, this disturbance of purchase and sale was done for 3 consecutive years and together with 6 companies. During this time, around two crore drugs were procured.

One more milestone: Lupin got USFDA approval for Desoximetasone topical spray

The company has received final approval for its Desoximetasone Topical Spray, 0.25%, 30 ml, 50 ml, and 100 ml from the United States Food and Drug

Drug market game, medicines sold without testing

In Chhattisgarh's Raipur, more than 20 thousand brand drugs have been sold for different diseases in bulk and chilhar drug market, but investigation is only going to be 6 in a month.

7 companies blacklisted in Tamil nadu for poor quality drugs

The Tamil Nadu Medical Services Corporation (TNMSC) has blacklisted seven manufacturing firms in the last one year for producing substandard drugs and products. Around 38 brands of drugs and devices made by these firms were banned after quality control checks found them to be below par.

FDA warns consumers not to use unapproved erectile dysfunction products advertised on the radio

The U.S. Food and Drug Administration is warning consumers not to purchase or use drugs advertised nationwide as a “healthy man alternative to the little blue pill” or “healthy man,” or “the power pill” for erectile dysfunction on broadcast and internet radio platforms such as iHeart Radio, as these drugs have not been approved by FDA.

Dr Reddy's launches allergy relief tablets in US

Drug firm Dr Reddy's Laboratories has launched levocetirizine dihydrochloride tablets, used for relieving allergies, in the US market.

Notice given to 14 drug companies

There is a shocking news from Asstalpura of Uttar Pradesh. Here, the team of the Department of Drugs procured more than one and a half million counterfeit medicines.

Dr Reddy’s Laboratories declines 3% on Form 483 from USFDA

The company has received Form 483 with 4 observations for its API Hyderabad Plant 1 at Jinnaram Mandal, Medak Telengana from USFDA.

Unichem Labs under regulator scanner for launching blood pressure medicines without price approval

Indian drug maker Unichem Laboratories has come under the National Pharmaceutical Pricing Authority’s scanner for allegedly launching six medicines for the treatment of high blood pressure years before it asked the pricing regulator to fix their retail prices.

Report: Torrent Pharma in talks to raise Rs 1,500 crore for Sanofi generics business bid

Torrent Pharma Ltd is looking to raise Rs 1,500 crore through a share sale to institutional investors, an effort to gather funds for its bid for Sanofi's generic drugs business Zenitva, according to a Mint report.

Cadila Healthcare up 2% on USFDA approval to market Tizanidine tablets

Shares of Cadila Healthcare added 2 percent intraday Tuesday as it has received USFDA nod for Tizanidine tablets.

The adhar card is essential for medication

Important news for all the beneficiaries involved in the Central Government Health Scheme (CGHS). The basis for all beneficiaries connected with CGHS has been made mandatory. The last date for linking the Aadhaar to the beneficiary's card is kept March 31. Even if the base link is not available then the beneficiaries will be deprived of facilities.